Autoimmune Disease Research Across NIH
NIH supports a broad range of basic to clinical research on autoimmunity and autoimmune diseases.
Portfolio Analysis
The Office of Autoimmune Disease Research (OADR-ORWH) is currently evaluating NIH’s autoimmune disease research (ADR) portfolio. In partnership with key subject matter experts, OADR-ORWH will curate and analyze research over the past 5 years to generate a baseline portfolio of funded research. For the purposes of this portfolio, OADR-ORWH is including the 144 diseases and conditions that were listed in the NASEM report, Enhancing NIH Research on Autoimmune Disease, as considered to be either autoimmune or co-exist with other autoimmune diseases suggesting potential commonalities in pathogenesis. These 144 diseases/conditions have been divided into 15 sub-portfolios for improved curation by subject matter expertise across different focus areas. The Office of Portfolio Analysis (OPA) supports the efforts to collate the initial sub-portfolios. The list of diseases/conditions and sub-portfolios are shown below.
Understanding the NIH ADR portfolio is critical to identifying opportunities to advance research and assess progress moving forward. This NIH-wide portfolio analysis will inform OADR-ORWH activities and the inaugural NIH-wide strategic plan for ADR.
Results of the ADR Portfolio Analysis will be released as they become available. Please monitor this page for updates.
